Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall recurrence and treatment failure. Patients with HRR-deficient metastatic ...
In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.